Cristiana Spontoni#4282

Cristiana Spontoni

Cristiana Spontoni is internationally recognised as a leader in life sciences, including biotechnology, pharmaceuticals, medical devices, food and cosmetics, as well as in general EU product and industries regulation. She is also actively involved in the shaping and interpretation of EU legislation affecting many different regulated industries and has successfully represented clients in legislative challenges based on EU law. Cristiana frequently coordinates large international assignments and provides comprehensive one-stop-shop solutions for cross-border regulatory issues affecting clients' operations. She has coordinated projects in more than 80 countries worldwide.

Cristiana advises clients from the pre-market phase, including clinical trials and pre-market authorisations, to post-market issues, including product liability, marketing/advertising, distribution, and compliance (including sector-specific antibribery and data privacy).

Cristiana handles safety and compliance issues for a large variety of clients both in the life sciences and consumer products sectors, including in regards to product regulation, crisis management (e.g., recalls), regulatory enforcement and media attacks, as well as in marketing/advertising/claims and associated substantiation matters.

Cristiana frequently speaks at and chairs major international conferences. She is recognised in the leading lawyer directories including Chambers, Legal 500, Best Lawyers, and International Who's Who and has received several important awards, including "Life Sciences Lawyer of the Year"(Corporate LiveWire 2018 Global Awards) and the ILO Client Choice Award for EU-wide Healthcare & Life Sciences. She has been named a "Star" by LMG Life Sciences and Acritas.)
Contributed to

2

The EU and UK General Data Protection Regulations—application in the life sciences sector
The EU and UK General Data Protection Regulations—application in the life sciences sector
Practice notes

This Practice Note gives an overview of those important changes that are provided in the General Data Protection Regulation, Regulation (EU) 2016/679 (EU GDPR) and the United Kingdom General Data Protection Regulation, Assimilated Regulation (EU) 2016/679 (UK GDPR), which affect life sciences companies and their businesses directly.

The use of Alternative Dispute Resolution in resolving life sciences disputes
The use of Alternative Dispute Resolution in resolving life sciences disputes
Practice notes

This Practice Note considers the advantages and limitations of using Alternative Dispute Resolution (ADR) rather than litigation to resolve life sciences disputes. It discusses the various forms of ADR (arbitration; mediation; expert determination; early neutral evaluation and adjudication) and provides some practical tips on how to take advantage of the different systems. It also sets out the most important institutions and bodies providing ADR for life sciences disputes, including the International Chamber of Commerce, International Centre for Dispute Resolution and the World Intellectual Property Organization Arbitration and Mediation Center, which is a more specialist body that specifically promotes arbitration and mediation in the life sciences sector.

Practice Area

Panels

  • Consulting Editorial Board
  • Contributing Author

Qualified Year

  • 2002

Membership

  • Brussels and Rome Bar Associations

Education

  • Collegio Europeo di Parma (LL.M. with distinction 1995)
  • Universita degli Studi di Roma "La Sapienza" (Law Degree summa cum laude 1994)

If you expected to see yourself on this page, click here.